Richmond American Announces Community Grand Opening in Umatilla
Seasons at Magnolia Pointe offers beautiful homes with designer-curated finishesUMATILLA, Fla., June 18, 2024 /PRNewswire/ -- Richmond American Homes of Florida, LP, a subsidiary of M.D.C. Holdings, Inc., is pleased to announce the Grand Opening of Seasons at Magnolia Pointe...
Ledgible Pioneers Digital Assets Tax Information Reporting For First of its Kind Tokenized Money Fund
ATLANTA, June 11, 2024 /PRNewswire/ -- Ledgible, the leading professional-first digital asset software platform for tax information reporting & compliance for digital assets, today announced their groundbreaking tax information reporting compliance operations."As federal regulations around digital assets, like IRS Form...
Federal Realty Investment Trust Completes Sale of Third Street Promenade Portfolio
Strategic Disposition Enhances Focus on Key Markets and Financial Flexibility
N. BETHESDA, Md., June 6, 2024 /PRNewswire/ -- Federal Realty Investment Trust (NYSE:FRT) announced today the sale of its remaining assets on Third Street Promenade in Santa Monica, California. The portfolio,...
KCU’s Dr. Rex Archer receives prestigious F. Douglas Scutchfield Leadership Award for work in public health
KANSAS CITY, Mo., June 21, 2024 /PRNewswire/ -- The Public Health Accreditation Board (PHAB) honored Rex Archer, MD, MPH, Kansas City University (KCU) professor and director of population and public health, with their esteemed F. Douglas Scutchfield Leadership Award...
American Homes 4 Rent Announces Pricing of Public Offering of $500 Million of 5.500% Senior Notes due 2034
LAS VEGAS, June 18, 2024 /PRNewswire/ -- American Homes 4 Rent (NYSE: AMH) (the "Company") today announced that its operating partnership, American Homes 4 Rent, L.P. (the "Operating Partnership"), has priced an offering of $500 million aggregate principal amount of...
Mozart Therapeutics Announces Oral Presentation on MTX-101 at the 2024 American Diabetes Association’s 84th Scientific Sessions
Data highlight potential of first-in-class CD8 Treg modulator
Phase 1 clinical trial underway to evaluate MTX-101 in healthy adults and patients with celiac disease or type 1 diabetes
SEATTLE, June 21, 2024 /PRNewswire/ -- Mozart Therapeutics, a clinical stage biopharmaceutical...